There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

The desire to lose weight is nothing new, and neither are medications to help. While there's a massive GLP-1 craze, these are weight loss medications have have existed prior to its release.

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 ...

A scientific study suggests that weight loss drugs could reduce the risk of several cancers associated with obesity.

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight.

Serena Williams said that roughly a year after starting a weight loss drug, she is the healthiest she has ever been and has ...

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...

Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts ...

Claire Munch says she was hospitalised with an eating disorder after a telehealth provider approved weight-loss drugs her GP had refused — and that even after she complained, she was later sent ...